BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 21782049)

  • 1. Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis.
    Rossini M; Zanotti R; Bonadonna P; Artuso A; Caruso B; Schena D; Vecchiato D; Bonifacio M; Viapiana O; Gatti D; Senna G; Riccio A; Passalacqua G; Pizzolo G; Adami S
    Bone; 2011 Oct; 49(4):880-5. PubMed ID: 21782049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis.
    van der Veer E; van der Goot W; de Monchy JG; Kluin-Nelemans HC; van Doormaal JJ
    Allergy; 2012 Mar; 67(3):431-8. PubMed ID: 22229787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis.
    Artuso A; Caimmi C; Tripi G; Viapiana O; Bonifacio M; Idolazzi L; Gavioli I; Gatti D; Zanotti R; Rossini M
    Calcif Tissue Int; 2017 Jan; 100(1):40-46. PubMed ID: 27743017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of new fragility fractures after diagnosis of indolent systemic mastocytosis.
    van der Veer E; Arends S; van der Hoek S; Versluijs JB; de Monchy JGR; Oude Elberink JNG; van Doormaal JJ
    J Allergy Clin Immunol; 2014 Dec; 134(6):1413-1421. PubMed ID: 24985401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An increased bone mineral density is an adverse prognostic factor in patients with systemic mastocytosis.
    Riffel P; Schwaab J; Lutz C; Naumann N; Metzgeroth G; Fabarius A; Schoenberg SO; Hofmann WK; Valent P; Reiter A; Jawhar M
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):945-951. PubMed ID: 31980928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of bone turnover to bone density and fractures.
    Melton LJ; Khosla S; Atkinson EJ; O'Fallon WM; Riggs BL
    J Bone Miner Res; 1997 Jul; 12(7):1083-91. PubMed ID: 9200008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone turnover markers are associated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study.
    Jørgensen HS; Winther S; Bøttcher M; Hauge EM; Rejnmark L; Svensson M; Ivarsen P
    BMC Nephrol; 2017 Sep; 18(1):284. PubMed ID: 28874132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone complications of mastocytosis: a link between clinical and biological characteristics.
    Guillaume N; Desoutter J; Chandesris O; Merlusca L; Henry I; Georgin-Lavialle S; Barete S; Hirsch I; Bouredji D; Royer B; Gruson B; Lok C; Sevestre H; Mentaverri R; Brazier M; Meynier J; Hermine O; Marolleau JP; Kamel S; Damaj G
    Am J Med; 2013 Jan; 126(1):75.e1-7. PubMed ID: 23200108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic mastocytosis and bone involvement in a cohort of 75 patients.
    Barete S; Assous N; de Gennes C; Grandpeix C; Feger F; Palmerini F; Dubreuil P; Arock M; Roux C; Launay JM; Fraitag S; Canioni D; Billemont B; Suarez F; Lanternier F; Lortholary O; Hermine O; Francès C
    Ann Rheum Dis; 2010 Oct; 69(10):1838-41. PubMed ID: 20570833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort.
    Yoshimura N; Muraki S; Oka H; Kawaguchi H; Nakamura K; Akune T
    Mod Rheumatol; 2011 Dec; 21(6):608-20. PubMed ID: 21512822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of monthly ibandronate on bone mineral density and bone turnover markers in patients with haemophilia A and B and increased risk for fracture.
    Anagnostis P; Vyzantiadis TA; Charizopoulou M; Adamidou F; Karras S; Goulis DG; Karagiannis A; Garipidou V; Vakalopoulou S
    Thromb Haemost; 2013 Aug; 110(2):257-63. PubMed ID: 23740140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis.
    Arends S; Spoorenberg A; Bruyn GA; Houtman PM; Leijsma MK; Kallenberg CG; Brouwer E; van der Veer E
    Osteoporos Int; 2011 May; 22(5):1431-9. PubMed ID: 20603707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density: serum markers of bone turnover and their relationships in peritoneal dialysis.
    Negri AL; Barone R; Quiroga MA; Bravo M; Marino A; Fradinger E; Bogado CE; Zanchetta JR
    Perit Dial Int; 2004; 24(2):163-8. PubMed ID: 15119637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis.
    Rossini M; Viapiana O; Zanotti R; Tripi G; Perbellini O; Idolazzi L; Bonifacio M; Adami S; Gatti D
    Calcif Tissue Int; 2015 May; 96(5):410-6. PubMed ID: 25694360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High bone turnover is associated with accelerated bone loss but not with increased fracture risk in men aged 50 and over: the prospective MINOS study.
    Szulc P; Montella A; Delmas PD
    Ann Rheum Dis; 2008 Sep; 67(9):1249-55. PubMed ID: 18065499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of osteopontin in the assessment of bone mineral density status in postmenopausal women.
    Fodor D; Bondor C; Albu A; Simon SP; Craciun A; Muntean L
    J Investig Med; 2013 Jan; 61(1):15-21. PubMed ID: 23117696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of gender and age on the association of apolipoprotein E epsilon4 with bone mineral density, bone turnover and the risk of fractures in older people.
    Pluijm SM; Dik MG; Jonker C; Deeg DJ; van Kamp GJ; Lips P
    Osteoporos Int; 2002 Sep; 13(9):701-9. PubMed ID: 12195533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mineral density and vertebral fractures in men.
    Legrand E; Chappard D; Pascaretti C; Duquenne M; Rondeau C; Simon Y; Rohmer V; Basle MF; Audran M
    Osteoporos Int; 1999; 10(4):265-70. PubMed ID: 10692973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic Acquired Osteosclerosis in a Middle-Aged Woman With Systemic Lupus Erythematosus.
    Guañabens N; Mumm S; Gifre L; Ruiz-Gaspà S; Demertzis JL; Stolina M; Novack DV; Whyte MP
    J Bone Miner Res; 2016 Sep; 31(9):1774-82. PubMed ID: 27005479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.